APA (7th ed.) Citation

R, U., RI, H., Y, T., C, L. T., NY, L., W, W., . . . D, A. (2025). Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer. The New England journal of medicine, 393(1), 37. https://doi.org/10.1056/NEJMoa2415434

Chicago Style (17th ed.) Citation

R, Uppaluri, et al. "Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer." The New England Journal of Medicine 393, no. 1 (2025): 37. https://doi.org/10.1056/NEJMoa2415434.

MLA (9th ed.) Citation

R, Uppaluri, et al. "Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer." The New England Journal of Medicine, vol. 393, no. 1, 2025, p. 37, https://doi.org/10.1056/NEJMoa2415434.